The 2008 William M. Feinberg lecture: prioritizing stroke research.
(1/27)
(+info)
Controversies in Alzheimer's disease drug development.
(2/27)
(+info)
Cell therapy for stroke: remaining issues to address before embarking on clinical trials.
(3/27)
(+info)
Challenges of designing trials for the primary prevention of stroke.
(4/27)
(+info)
National Institute of Neurological Disorders and Stroke support for brain-machine interface technology.
(5/27)
(+info)
Defining future directions in spinal cord tumor research: proceedings from the National Institutes of Health workshop.
(6/27)
(+info)
Years of disability-adjusted life gained as a result of thrombolytic therapy for acute ischemic stroke.
(7/27)
(+info)
A matching algorithm to address imbalances in study populations: application to the National Institute of Neurological Diseases and Stroke Recombinant Tissue Plasminogen Activator acute stroke trial.
(8/27)
(+info)